A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine
Copyright © 2021, Malayala et al..
Vaccination is now considered the best measure in minimizing the morbidity and mortality from the Covid-19 pandemic. Almost all the vaccines are considered safe except for minor and occasional side effects. Some of the commonly reported complications from the COVID-19 vaccines are vaccine-induced thrombotic thrombocytopenia (VITT)/thrombosis with thrombocytopenia syndrome/vaccine-induced pro-thrombotic immune thrombocytopenia syndrome. In this case report, we present a case of a 75-year-old female who had an uncomplicated first and second vaccine dose but developed VITT after the booster dose of the vaccine. The patient was treated with dexamethasone and platelet transfusions. So far no such cases have been reported after the third (booster) dose of the Pfizer-Biontech vaccine. With this case report, we present the case of the patient and discuss the literature related to vaccine-induced thrombocytopenia.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Cureus - 13(2021), 10 vom: 03. Okt., Seite e18985 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Malayala, Srikrishna V [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 26.11.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.7759/cureus.18985 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333574230 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333574230 | ||
| 003 | DE-627 | ||
| 005 | 20231225221925.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7759/cureus.18985 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1111.xml |
| 035 | |a (DE-627)NLM333574230 | ||
| 035 | |a (NLM)34820240 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Malayala, Srikrishna V |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.11.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2021, Malayala et al. | ||
| 520 | |a Vaccination is now considered the best measure in minimizing the morbidity and mortality from the Covid-19 pandemic. Almost all the vaccines are considered safe except for minor and occasional side effects. Some of the commonly reported complications from the COVID-19 vaccines are vaccine-induced thrombotic thrombocytopenia (VITT)/thrombosis with thrombocytopenia syndrome/vaccine-induced pro-thrombotic immune thrombocytopenia syndrome. In this case report, we present a case of a 75-year-old female who had an uncomplicated first and second vaccine dose but developed VITT after the booster dose of the vaccine. The patient was treated with dexamethasone and platelet transfusions. So far no such cases have been reported after the third (booster) dose of the Pfizer-Biontech vaccine. With this case report, we present the case of the patient and discuss the literature related to vaccine-induced thrombocytopenia | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a booster side effects | |
| 650 | 4 | |a covid 19 | |
| 650 | 4 | |a covid associated thrombocytopenia | |
| 650 | 4 | |a covid-19 vaccine | |
| 650 | 4 | |a covid-19 vaccine complication | |
| 650 | 4 | |a drug-induced itp | |
| 650 | 4 | |a idiopathic thrombocytopenic purpura | |
| 650 | 4 | |a mrna-based vaccine | |
| 650 | 4 | |a pfizer-biontech covid-19 vaccine | |
| 650 | 4 | |a vaccine side effects | |
| 700 | 1 | |a Papudesi, Bhavani N |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Rishika |e verfasserin |4 aut | |
| 700 | 1 | |a Vusqa, Urwat T |e verfasserin |4 aut | |
| 700 | 1 | |a Raza, Ambreen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 13(2021), 10 vom: 03. Okt., Seite e18985 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:10 |g day:03 |g month:10 |g pages:e18985 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.18985 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2021 |e 10 |b 03 |c 10 |h e18985 | ||